Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach

about

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach

Item

http://www.wikidata.org/entity/Q28601378

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@ast

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@en

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@nl

type

Item

label

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@ast

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@en

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@nl

prefLabel

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@ast

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@en

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@nl

P1476

Defining the Active Fraction o ...... c and Pharmacodynamic Approach

@en

P2093

Alan Forrest

http://www.w3.org/2001/XMLSchema#string

Brian T Tsuji

http://www.w3.org/2001/XMLSchema#string

Patricia N Holden

http://www.w3.org/2001/XMLSchema#string

Samira M Garonzik

http://www.w3.org/2001/XMLSchema#string

P2860

Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes.

Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model.

New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.

Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion.

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections.

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.

Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Protein binding: do we ever learn?

P304

e0156131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

880621

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0156131

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juergen Bulitta

Justin R Lenhard

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27284923

http://www.w3.org/2001/XMLSchema#string

P921

pharmacokinetics

methicillin-resistant Staphylococcus aureus

pharmacodynamics

P932

4902307

http://www.w3.org/2001/XMLSchema#string